These findings are supported by preclinical data, which demonstrated that [89Zr]Zr-cetuximab tumor uptake not only is dependent on EGFR expression but also is influenced by other pharmacokinetic and dynamic mechanisms [10]. This evidence concerns the gene EGFR and neoplasm.